Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2018

View Archived Issues

Adipose-derived regenerative cell therapy safe in patients with erectile dysfunction

Polymorphisms in miRNA-146a and IRAK1 are associated with susceptibility to SLE and MS

Harbour BioMed licenses ex-China rights to Kelun-Biotech's A-167

Common pathway may underlie schizophrenia and PD

Getting at stored mRNAs part of fragile X problem

HDAC inhibitors optimized for CNS drug-like properties and hematological safety

Phase Ib data guide Novan's development of SB-414 for atopic dermatitis

New oral selective apelin agonist AM-2995 developed for heart disease treatment

Chugai's describes candidate for the treatment of hyperphosphatemia EOS-798

Novo Nordisk reports topline PIONEER 5 results for oral semaglutide

Phase III study of MC2-01 cream in psoriasis vulgaris meets primary and secondary endpoints

Biogen identifies new NRF2 activators

Adare Pharmaceuticals describes cysteamine prodrugs

Antiangiogenic compounds synthesized at Celgene

Vectura completes pediatric studies with VR-647 for asthma

Hanmi Science patents oncolytic compounds

New Rho kinase inhibitors described by Chiesi Farmaceutici

Japanese approval for Tagrisso as first-line treatment of EGFR-mutated NSCLC

Phase II trial of TLC-599 for osteoarthritis pain meets primary and key secondary endpoints

FDA approves expanded label for Keytruda for first-line treatment of metastatic non-squamous NSCLC

Ascentage Pharma opens phase I trial of APG-2575 in hematologic malignancies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...